292 related articles for article (PubMed ID: 11469860)
1. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
[TBL] [Abstract][Full Text] [Related]
2. Structure of cytochrome P450eryF: substrate, inhibitors, and model compounds bound in the active site.
Cupp-Vickery JR; Poulos TL
Steroids; 1997 Jan; 62(1):112-6. PubMed ID: 9029724
[TBL] [Abstract][Full Text] [Related]
3. 7-Benzyloxyquinoline oxidation by P450eryF A245T: finding of a new fluorescent substrate probe.
Khan KK; Halpert JR
Chem Res Toxicol; 2002 Jun; 15(6):806-14. PubMed ID: 12067248
[TBL] [Abstract][Full Text] [Related]
4. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
[TBL] [Abstract][Full Text] [Related]
5. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
6. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
[TBL] [Abstract][Full Text] [Related]
7. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
Lüdemann SK; Lounnas V; Wade RC
J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF.
Nagano S; Cupp-Vickery JR; Poulos TL
J Biol Chem; 2005 Jun; 280(23):22102-7. PubMed ID: 15824115
[TBL] [Abstract][Full Text] [Related]
9. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
10. Azole drugs trap cytochrome P450 EryK in alternative conformational states.
Montemiglio LC; Gianni S; Vallone B; Savino C
Biochemistry; 2010 Nov; 49(43):9199-206. PubMed ID: 20845962
[TBL] [Abstract][Full Text] [Related]
11. Active site analysis of P450 enzymes: comparative magnetic circular dichroism spectroscopy.
Andersson LA; Johnson AK; Peterson JA
Arch Biochem Biophys; 1997 Sep; 345(1):79-87. PubMed ID: 9281314
[TBL] [Abstract][Full Text] [Related]
12. Allosteric mechanisms in P450eryF probed with 1-pyrenebutanol, a novel fluorescent substrate.
Davydov DR; Kumar S; Halpert JR
Biochem Biophys Res Commun; 2002 Jun; 294(4):806-12. PubMed ID: 12061778
[TBL] [Abstract][Full Text] [Related]
13. On the mechanism of biological methane formation: structural evidence for conformational changes in methyl-coenzyme M reductase upon substrate binding.
Grabarse W; Mahlert F; Duin EC; Goubeaud M; Shima S; Thauer RK; Lamzin V; Ermler U
J Mol Biol; 2001 May; 309(1):315-30. PubMed ID: 11491299
[TBL] [Abstract][Full Text] [Related]
14. Conformational dynamics in cytochrome P450-substrate interactions.
Li H; Poulos TL
Biochimie; 1996; 78(8-9):695-9. PubMed ID: 9010597
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.
Cupp-Vickery J; Anderson R; Hatziris Z
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3050-5. PubMed ID: 10716705
[TBL] [Abstract][Full Text] [Related]
16. Preliminary crystallographic analysis of an enzyme involved in erythromycin biosynthesis: cytochrome P450eryF.
Cupp-Vickery JR; Li H; Poulos TL
Proteins; 1994 Oct; 20(2):197-201. PubMed ID: 7846029
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
[TBL] [Abstract][Full Text] [Related]
18. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
Bambal RB; Hanzlik RP
Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
[TBL] [Abstract][Full Text] [Related]
19. Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
Kirton SB; Murray CW; Verdonk ML; Taylor RD
Proteins; 2005 Mar; 58(4):836-44. PubMed ID: 15651036
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
